Optimizing Multiplexed Detections of Diabetes Antibodies via Quantitative Microfluidic Droplet Array

Area of Science:

• Biomedical Engineering
• Immunology
• Analytical Chemistry

Background:

• Early detection of diabetes is crucial for patient management and prevention of complications.
• Current assays for diabetes antibodies can be time-consuming and lack sensitivity for early screening.
• Multiplexed detection of multiple autoantibodies offers a comprehensive approach to diabetes immunoprofiling.

Purpose of the Study:

• To develop a sensitive, single-volume assay for the simultaneous detection of multiple diabetes-related antibodies.
• To enhance reagent transport and assay speed using microfluidic technology and porous hydrogel droplets.
• To establish a robust and efficient method for diabetes antibody detection for clinical screening.

Main Methods:

• Leveraging porous hydrogel droplets in microfluidic serpentine arrays for enhanced reagent transport.
• Applying a spatially multiplexed assay for the detection of antibodies against insulin, GAD65, and IA-2.
• Optimizing assay protocols to reduce assay time and improve detection limits.

Main Results:

• Achieved a shortened assay time of 2 hours with detection limits better than 20 pg/mL for all three antibodies.
• Demonstrated negligible background and non-specific binding, ensuring high specificity.
• Enabled multiplexed detection with accuracy within 15% of target concentrations across a wide range.

Conclusions:

• The developed microfluidic assay enables sensitive, single-volume, multiplexed detection of diabetes antibodies.
• This technique allows for the quantification of as few as 8000 molecules per droplet, facilitating early screening and monitoring.
• The breakthrough is essential for the future clinical adoption of diabetes antibody panels.